AMIGO
IHI Call 9
Contact
Prof. Dr.Christoph Klein
Dr.von Hauner Children’s Hospital Munich, Germany
christoph.klein@med.uni-muenchen.de
Nicola Götzenberger
Global Liaison Manager
Dr.von Hauner Children’s Hospital Munich, Germany
Nicola.Goetzenberger@med.uni-muenchen.de
Further Information on Brokerage Platform:
AMIGO Proposal Link
Christoph Klein Profile Link
Is your project suitable for IHI?
Public Private Partnerships are essential:
- To provide access to hospital-based databases
- To secure continuous expansion of databases
- To enable cutting-edge analysis of data
- To empower a journey of investigation leading to precision medicine for children and adults with rare and common immunological diseases
Contribution through collaboration
- Real time access allows development in-time
- Early involvement and access secures targeted project progress
- New marketing strategies will be established
Approach to solve the problem
Innovative ecosystem
Ensure evolution from pediatric immunological diseases to general adult care -paving the way to personalized medicine
Outcomes and Impacts
- Access to precious multi-omics data (of > 10.000 European patients)
- Technological Independence
- Joint forces of leading European Children’s Hospitals
Innovative ecosystem will empower target identification and validation via multi-omics analysis in immunological disorders.
European Union’s health industry will be strengthened to become competitive on a global level by collecting and using European patient data.
Patients will benefit by collaboration, gradual roll-out, and design of novel diagnostic methods and therapeutic strategies establishing personalized medicine.
Expertise and Resources
We offer:
- Leading European scientists in Immune Disorders
- Network of European Children‘s Hospitals (ECHO)
- Access to >10.000 Patient Data
We need:
- Target-to-Drug Expertise
- Data-to-AI Expertise
- Clinical Trial Support
Joint initiative of
